Skip to content
Med Pharma News

Med Pharma News

Your Daily Dose of Pharma News

  • About Med Pharma News
  • Contact Us
  • News
  • Privacy Policy
  • Terms and Conditions
Novo Nordisk layoffs infographic: 215 jobs cut at Plainsboro US headquarters
  • Industry Insights
43 minutes ago

Novo Nordisk Layoffs: 215 More Jobs Cut at US Headquarters in Sales Overhaul

Novo Nordisk will cut 215 jobs at its Plainsboro, New Jersey headquarters in February 2027, taking 2026 US HQ cuts to 323 as it redesigns its sales force.

  • MAHA ELEVATE Model: CMS Awards $47M to 15 Groups to Test Lifestyle Medicine in Medicare
  • AI Drug Discovery Timelines: Big Pharma Says Early Research Now Runs Up to Twice as Fast
  • UnitedHealth Star Ratings Lawsuit: Insurer Sues CMS Over 45 Medicare Advantage Contracts
MAHA ELEVATE model infographic: $47 million to 15 organisations from 450 applications
  • Industry Insights
5 hours ago

MAHA ELEVATE Model: CMS Awards $47M to 15 Groups to Test Lifestyle Medicine in Medicare

HHS and CMS awarded $47 million to 15 organisations under the MAHA ELEVATE model to test nutrition and exercise programmes for chronic disease in Original Medicare.

  • Novo Nordisk Layoffs: 215 More Jobs Cut at US Headquarters in Sales Overhaul
  • AI Drug Discovery Timelines: Big Pharma Says Early Research Now Runs Up to Twice as Fast
  • UnitedHealth Star Ratings Lawsuit: Insurer Sues CMS Over 45 Medicare Advantage Contracts
Rasonque EU approval infographic showing daraxonrasib survival of 13.2 months versus 6.7 months on chemotherapy
  • Pharmaceuticals
6 hours ago

Rasonque EU Approval: Daraxonrasib Becomes Europe’s First RAS Pill for Pancreatic Cancer

The European Commission has approved Revolution Medicines’ Rasonque (daraxonrasib) for previously treated metastatic pancreatic cancer, with or without a RAS mutation. Here is what the label covers and when patients may get it.

  • Barzolvolimab Atopic Dermatitis Trial Fails: Celldex Drops Eczema to Focus on Hives
  • Savara Molgramostim FDA Decision Delayed: No New Date for First aPAP Drug
  • Xanamem Alzheimer’s Trial Misses Main Goal, Actinogen Shares Plunge Over 80%
Barzolvolimab atopic dermatitis Phase 2 results infographic
  • Pharmaceuticals
8 hours ago8 hours ago

Barzolvolimab Atopic Dermatitis Trial Fails: Celldex Drops Eczema to Focus on Hives

Celldex is ending barzolvolimab development in atopic dermatitis after a 131-patient Phase 2 missed its itch endpoint at both doses. The data, the biology behind the miss and what remains in the pipeline.

  • Rasonque EU Approval: Daraxonrasib Becomes Europe’s First RAS Pill for Pancreatic Cancer
  • Savara Molgramostim FDA Decision Delayed: No New Date for First aPAP Drug
  • Xanamem Alzheimer’s Trial Misses Main Goal, Actinogen Shares Plunge Over 80%
  • Industry Insights

Regenerative Medicine Scaffolds Market Revenue, Trends, and Strategic Insights by 2032

Megan Wood 43 minutes ago
  • Pharmaceuticals

6 Immunity-Boosting Drinks to Combat Winter Sickness

Megan Wood 43 minutes ago
Novo Nordisk layoffs infographic: 215 jobs cut at Plainsboro US headquarters
  • Industry Insights

Novo Nordisk Layoffs: 215 More Jobs Cut at US Headquarters in Sales Overhaul

Megan Wood43 minutes ago09 mins

Novo Nordisk will cut 215 jobs at its Plainsboro, New Jersey headquarters in February 2027, taking 2026 US HQ cuts to 323 as it redesigns its sales force.

Read More
MAHA ELEVATE model infographic: $47 million to 15 organisations from 450 applications
  • Industry Insights

MAHA ELEVATE Model: CMS Awards $47M to 15 Groups to Test Lifestyle Medicine in Medicare

Megan Wood5 hours ago09 mins

HHS and CMS awarded $47 million to 15 organisations under the MAHA ELEVATE model to test nutrition and exercise programmes for chronic disease in Original Medicare.

Read More
Rasonque EU approval infographic showing daraxonrasib survival of 13.2 months versus 6.7 months on chemotherapy
  • Pharmaceuticals

Rasonque EU Approval: Daraxonrasib Becomes Europe’s First RAS Pill for Pancreatic Cancer

Megan Wood6 hours ago010 mins

The European Commission has approved Revolution Medicines’ Rasonque (daraxonrasib) for previously treated metastatic pancreatic cancer, with or without a RAS mutation. Here is what the label covers and when patients may get it.

Read More
Barzolvolimab atopic dermatitis Phase 2 results infographic
  • Pharmaceuticals

Barzolvolimab Atopic Dermatitis Trial Fails: Celldex Drops Eczema to Focus on Hives

Megan Wood8 hours ago8 hours ago09 mins

Celldex is ending barzolvolimab development in atopic dermatitis after a 131-patient Phase 2 missed its itch endpoint at both doses. The data, the biology behind the miss and what remains in the pipeline.

Read More
Savara molgramostim FDA delay infographic for autoimmune pulmonary alveolar proteinosis
  • Pharmaceuticals

Savara Molgramostim FDA Decision Delayed: No New Date for First aPAP Drug

Megan Wood9 hours ago010 mins

The FDA will miss the 22 November goal date for Savara’s inhaled molgramostim in autoimmune PAP and has set no new date. What happened, the regulatory history and what analysts expect.

Read More
Xanamem Alzheimer's trial infographic: XanaMIA CDR-SB result, 247 patients, over-75 subgroup
  • Pharmaceuticals

Xanamem Alzheimer’s Trial Misses Main Goal, Actinogen Shares Plunge Over 80%

Megan Wood1 day ago010 mins

Actinogen’s oral Xanamem missed its CDR-SB primary endpoint in the 247-patient XanaMIA Alzheimer’s trial. We explain the over-75 subgroup signal, the share collapse and what comes next.

Read More
AI drug discovery timelines infographic with Novartis, Novo Nordisk and market data
  • Industry Insights

AI Drug Discovery Timelines: Big Pharma Says Early Research Now Runs Up to Twice as Fast

Megan Wood1 day ago011 mins

Novartis, Novo, Sanofi, BMS and others say AI has cut early drug discovery time by up to half. The numbers, the frontier AI rivalry and what has not changed.

Read More
UnitedHealth star ratings lawsuit infographic showing 45 contracts and 26 disputed measures
  • Industry Insights

UnitedHealth Star Ratings Lawsuit: Insurer Sues CMS Over 45 Medicare Advantage Contracts

Megan Wood1 day ago09 mins

UnitedHealth sues CMS over 2027 Medicare Advantage star ratings for 45 contracts, claiming up to 1.5 stars were lost. What is at stake and what comes next.

Read More
Merck sac-TMT trial infographic: TroFuse-015 overall survival win in gastroesophageal cancer
  • Pharmaceuticals

Merck sac-TMT Trial Wins on Survival in Late-Line Gastroesophageal Cancer, Misses on PFS

Megan Wood1 day ago09 mins

TroFuse-015 met its overall survival goal for Merck and Kelun’s TROP2 ADC sac-TMT in 473 pretreated gastroesophageal cancer patients, but missed progression-free survival.

Read More
  • 1
  • 2
  • 3
  • …
  • 64

Categories

  • Healthcare IT (26)
  • Industry Insights (369)
  • Lifestyle and Wellness (24)
  • Medical Devices (45)
  • Pharmaceuticals (116)
  • Uncategorized (1)

Recent Posts

  • Novo Nordisk Layoffs: 215 More Jobs Cut at US Headquarters in Sales Overhaul
  • MAHA ELEVATE Model: CMS Awards $47M to 15 Groups to Test Lifestyle Medicine in Medicare
  • Rasonque EU Approval: Daraxonrasib Becomes Europe’s First RAS Pill for Pancreatic Cancer
  • Barzolvolimab Atopic Dermatitis Trial Fails: Celldex Drops Eczema to Focus on Hives
  • Savara Molgramostim FDA Decision Delayed: No New Date for First aPAP Drug

You May Have Missed

Walking Assist Devices Market Revenue, Trends, and Strategic Insights by 2032
  • Industry Insights

Walking Assist Devices Market Revenue, Trends, and Strategic Insights by 2032

Megan Wood 6 months ago
AI in Biotechnology Market Revenue, Trends, and Strategic Insights by 2035
  • Industry Insights

AI in Biotechnology Market Revenue, Trends, and Strategic Insights by 2035

Megan Wood 6 months ago
Colposcopy Market Revenue, Trends, and Strategic Insights by 2030
  • Industry Insights

Colposcopy Market Revenue, Trends, and Strategic Insights by 2030

Megan Wood 5 months ago
Baby Memorial Hospital DeepInfinity AI partnership graphic about the single-vendor AI model
  • Healthcare IT

Baby Memorial Hospital DeepInfinity AI Partnership: The Business Case for One AI Partner

Megan Wood 3 weeks ago
Graphic: Biopharma SHAKTI pilot of 25 clinical trial sites stepping toward the 1,000-site target
  • Industry Insights

Biopharma SHAKTI Gets a Strong Start With 25 Trial Sites

Megan Wood 1 month ago1 month ago
Hemodialysis Catheters Market Revenue, Trends, and Strategic Insights by 2030
  • Industry Insights

Hemodialysis Catheters Market Revenue, Trends, and Strategic Insights by 2030

Megan Wood 6 months ago
Small Animal Imaging Market Revenue, Trends, and Strategic Insights by 2032
  • Industry Insights

Small Animal Imaging Market Revenue, Trends, and Strategic Insights by 2032

Megan Wood 7 months ago
Smart Contact Lenses Market
  • Industry Insights

Smart Contact Lenses Market Revenue, Trends, and Strategic Insights by 2032

Megan Wood 10 months ago
Digital Newspaper - Multipurpose News WordPress Theme 2026. Powered By BlazeThemes.